CompletedNot Applicable

Determining the Efficacy of Essential Oil Aromatherapy in Children Undergoing Port Access

United States23 participantsStarted 2023-12-05

Plain-language summary

The purpose of this study is to determine if the use of aromatherapy impacts patient anxiety and pain scores surrounding port access in pediatric oncology patients between the ages of 4 years and 18 years.

Who can participate

Age range4 Years – 18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Children between 4 years and 18 years
✓. Scheduled for port access with or without lab draw
✓. Oncology, neuro-oncology, and stem cell transplant patients

Exclusion criteria

✕. has asthma, reactive airway disease, or allergies to any of the ingredients we are using in the aromatherapy study (lavender, bergamot, sweet orange, and ylang ylang)
✕. currently uses aromatherapy for port accesses or other painful procedures (does not apply to patients using aromatherapy, such as peppermint oil, for nausea)
✕. has a cognitive impairment that prevents them from being able to provide anxiety or pain scores
✕. does not wish to participate in the study

What they're measuring

Effect of aromatherapy on post patient anxiety scores

Timeframe: 5 minutes

Trial details

NCT IDNCT05696899

SponsorStanford University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-05-30

View on ClinicalTrials.gov More Anxiety and Fear trials